Oxford Vacmedix UK Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Oxford Vacmedix UK Limited - overview
Established
2012
Location
Oxford, -, UK
Primary Industry
Pharmaceuticals
About
Founded in 2012 and based in Oxford, US, Oxford Vacmedix UK Limited operates as a developer of immunotherapy for the treatment of cancer.
Current Investors
Cancer Rop Co., Ltd.
Primary Industry
Pharmaceuticals
Sub Industries
Oncology/Cancer Treatment, Pharmaceutical Research & Development
Website
www.oxfordvacmedix.com
Company Stage
Series A
Total Amount Raised
Subscriber access only
Oxford Vacmedix UK Limited - timeline of key events
Oxford Vacmedix UK Limited - financials
| Fiscal Year Ended | Mar 31, 2013 | Mar 31, 2014 | Mar 31, 2015 | Mar 31, 2016 | Mar 31, 2017 | Mar 31, 2018 | Mar 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | - | - | - | - | - | - | - | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA (USD) | - | - | - | - | - | - | - | (2,814,711) | (2,891,054) | - | - | - |
| Operating Income (USD) | - | - | - | - | - | - | - | (2,840,371) | (2,947,649) | - | - | - |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - |
| % EBITDA Margin | - | - | - | - | - | - | - | - | - | - | - | - |
| NET Income (USD) | (92,686.8) | (7,649) | (12,574) | - | - | - | - | (2,306,723) | (2,500,111) | - | - | - |
| % Net Margin | - | - | - | - | - | - | - | - | - | - | - | - |
Oxford Vacmedix UK Limited - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.